Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 22, 2015 8:16 AM ET

Life Sciences Tools and Services

Company Overview of Lifeline Cell Technology, LLC

Company Overview

Lifeline Cell Technology, LLC develops, manufactures, and markets purified primary human cells and optimized reagents for cell culture. It offers adipose, bladder, blood immune system, bone marrow, breast, cardiovascular, cornea, iPS validated fibroblasts, kidney, lung-airway, prostate, reproductive, skin, and umbilical cord tissue types; and cell types, including endothelial, epithelial, fibroblast, iPS validated fibroblasts, melanocytes, hematopoietic, smooth muscle, human and non-human stem cells. The company also provides cell culture media, such as blood immune systems, endothelial-large and small vessel, epithelial, fibroblast, neuronal, smooth muscle, and human stem cells; and additio...

8415 Progress Drive

Suite T

Frederick, MD 21701

United States

Founded in 2001

Phone:

240-439-4448

Fax:

301-845-2405

Key Executives for Lifeline Cell Technology, LLC

Co-Founder and Director of Quality Control
Chief Financial Officer and Managing Member
Age: 71
President of International Stem Cell Corporation
Age: 51
Senior Vice President
Compensation as of Fiscal Year 2014.

Lifeline Cell Technology, LLC Key Developments

Lifeline Cell Technology Expands Asian Distribution Network

International Stem Cell Corporation announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania. Lifeline Cell Technology (LCT) has expanded its overseas network by adding new distributors in several fast-growing territories including Korea, Taiwan, Australia, New Zealand and India. LCT develops, manufactures and commercializes over 130 human cell culture products. These products include frozen human adult or primary cells, adult stem cells and the reagents (called media) needed to grow, maintain and differentiate such cells. These human cell-based products are used by research scientists in pharmaceutical, academic and government research organizations to study human diseases and basic cell biology. LCT's products provide value and quality by eliminating the need for scientists to source their own cells or develop their own media. Strict quality assurance ensures a high level of consistency and standardization, which along with a high level of customer service, makes LCT's products the first choice for many scientists.

Similar Private Companies By Industry

Company Name Region
Drik LLC United States
BioLogics, Inc. United States
Hill Top Research Corporation United States
Provident Clinical Research and Consulting, Inc. United States
Pharma Trials International, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lifeline Cell Technology, LLC, please visit www.lifelinecelltech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.